Multiple Myeloma With Symptomatic Progression
Multiple Myeloma With High-Risk Features
July 2017
Isa-Kd Stands Out Among Subsequent Regimens in Multiple Myeloma
April 4th 2024During a Case-Based Roundtable® event, Cristiana Costa Chase, MD, discussed the recommended regimens and trials supporting therapies following lenalidomide-refractory relapse of multiple myeloma in the second article of a 2-part series.
Read More